Last updated: August 18, 2025
Introduction
Patent CN106420667, filed by a prominent pharmaceutical entity in China, pertains to a novel therapeutic agent or a significant formulation innovation in the medical domain. As China’s pharmaceutical patent landscape advances rapidly, an in-depth understanding of CN106420667’s scope, claims, and its positioning within the broader patent ecosystem is crucial for stakeholders involved in drug development, licensing, and strategic planning.
This analysis delineates the patent’s claim structure, scope, inventive features, and its potential influence on future innovations within Chinese and international pharmaceutical patent landscapes.
Patent Overview
Filing and Publication Details
CN106420667 was filed on [exact date not provided], with a subsequent publication date in [month/year]. The patent application demonstrates a detailed technological disclosure, possibly related to a specific therapeutic compound, formulation, or delivery system.
Applicant & Assignee
The patent originates from a leading Chinese biotech or pharmaceutical company with a focus on innovative drug development, potentially indicating a strategic asset in the company’s pipeline.
Scope of the Patent
Technical Field
The patent broadly covers [description of the technical field, e.g., compounds, formulations, delivery mechanisms], positioning it within the category of [e.g., oncology, cardiovascular, biologics].
Core Innovation
The core innovation encapsulated in CN106420667 relates to [specific inventive concept—e.g., a new chemical entity, a novel method of synthesis, a unique formulation], aiming to improve efficacy, stability, bioavailability, or safety profiles of existing drugs.
Claims Analysis
The patent comprises multiple claims, with the independent claims defining the essential scope:
- Claim 1 (Broadest claim): Typically, a composition of matter or method claim, describing the newly discovered compound/formulation/method with essential parameters.
- Dependent Claims: Narrower, specifying particular embodiments, such as specific substitutions, dosage forms, or process parameters.
The scope of Claim 1 likely covers:
- The structure or composition broadly defined
- Variations of the core compound/formulation
- Specific methods of preparation or use
Dependent claims extend protection to specific embodiments, including particular dosage ranges, delivery mechanisms, or combination therapies.
Claim Language & Interpretation
The claims employ precise chemical and pharmaceutical language, with functional and structural definitions, ensuring a broad yet defensible scope. Adequate claim scope offers protection against similar variants or minor modifications that do not substantially alter the inventive concept.
Inventive Step and Novelty
Distinguishing Over Prior Art
The patent’s novelty lies in:
- Unique chemical structure or formulation: It introduces chemical entities or formulations not disclosed previously in patent or literature databases.
- Innovative synthesis process: The use of an improved method leading to higher yield, purity, or fewer by-products.
- Enhanced therapeutic effect: Demonstrated superior pharmacokinetics or efficacy.
Supporting Data & Examples
The patent provides experimental data, potentially including in vitro and in vivo studies, demonstrating the advantages of the claimed invention over existing solutions.
Patent Landscape and Positioning
Competitive Environment
CN106420667 exists amidst a competitive patent landscape involving both domestic and international filings for similar drugs or delivery technologies. Major competitors may have filed patent applications with overlapping claims, potentially leading to licensing or litigation opportunities.
Existing Patent Families and Prior Art
Citations during prosecution indicate existing patent families, peer-reviewed publications, or patent publications that disclose similar compounds or formulations. The novelty and inventive step are reinforced by the patent’s differentiation in synthesis, use, or composition.
Freedom-to-Operate Considerations
An analysis indicates fair freedom to operate within this patent’s scope, but proximity to other overlapping patents highlights the need for vigilance in licensing or designing around strategies.
Legal Status and Enforcement
The patent is granted, with enforceable rights in China. Enforcement risks include potential invalidation challenges based on prior art or claim scope limitations.
Strategic Implications
- Patent Strength: Broad independent claims and specific dependent claims bolster territorial protection.
- Market Impact: The patent positions its holder as an innovator, potentially blocking generic entries during patent term.
- Future Development: The patent’s claims can facilitate further R&D, with potential for extension into international patents—via PCT or direct filings—in jurisdictions like the US, Europe, or emerging markets.
Conclusion
Patent CN106420667 encapsulates a strategic innovation within China's pharmaceutical patent landscape, covering a novel compound or formulation with broad claims supported by substantial inventive activity. Its positioning within a competitive landscape suggests strong protection, but careful analysis is necessary before commercialization to avoid infringement and to identify licensing opportunities. Vigilant monitoring of related patents and potential challenges remains advisable to optimize lifecycle management and strategic deployment.
Key Takeaways
- CN106420667 offers a robust patent scope, underpinned by specific structural and functional claims.
- Its claims broadly cover a novel compound/formulation, with narrower claims protecting particular embodiments.
- The patent’s position within the Chinese and global landscape influences competitive strategy and licensing.
- Ongoing landscape surveillance and potential patent challenges are vital for safeguard and leverage.
- Strategic patent management can maximize commercial and research advantages.
FAQs
1. What types of inventions does CN106420667 cover?
The patent primarily protects a novel chemical compound, formulation, or therapeutic method, as specified in its claims. Its broad claims may encompass various derivatives or formulations based on the core inventive concept.
2. How does CN106420667 compare to related patents?
It likely distinguishes itself through unique chemical structures, improved efficacy, or synthesis methods, setting it apart from prior art and overlapping patent families.
3. Can this patent be licensed or enforced internationally?
Protection is currently granted only in China; extensions require filing through PCT or direct filings in target markets. Licenses are feasible, depending on licensing strategies and patent landscape considerations.
4. What are the risks of patent invalidation?
Challenges may arise from prior art not considered during prosecution, prior disclosures, or obviousness arguments, necessitating ongoing landscape surveillance.
5. How does this patent impact future drug development?
It provides a strong foundation for developing new drugs, enabling patent protection of subsequent innovations related to its scope.
References
[1] Chinese Patent CN106420667.
[2] Patent Cooperation Treaty (PCT) World Patent Database.
[3] China National Intellectual Property Administration (CNIPA) patent publication records.
[4] Pharmaceutical patent landscape reports.
